SeqOne
Smarter Genomics Platform
Montpellier, France · Founded 2017 · $48.9M raised
- Headquarters
- Montpellier
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- seqone.com
- Total Funding
- $48.9M
- Last Round
- $23.0M Growth EquityMay 2025
- Rounds
- 3
About
SeqOne is a leading European AI-powered bioinformatics company that equips molecular labs with next-generation sequencing (NGS) analysis software for oncology, rare diseases, and hereditary conditions. Founded in Montpellier, France, its cloud-based platform streamlines genomic data analysis — covering somatic and germline testing, liquid biopsy, and advanced biomarkers — enabling labs to deliver faster, more precise diagnoses at scale. As of 2025, SeqOne serves 140+ molecular labs across 30+ countries and has become the world's largest software pure-player in clinical genomics following its acquisition of UK genomics pioneer Congenica.
Summary
SeqOne is an Artificial Intelligence company based in Montpellier, France, founded in 2017. It has raised $48.9M in total across 3 rounds, most recently a $23.0M Growth Equity round in May 2025. Investors include Mérieux Equity Partners, Omnes Capital and Elaia.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company